ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
18.473,29
-1,13%
S&P 500
5.266,95
-0,74%
Dow Jones
38.441,54
-1,06%
Euro vs US Dollar
1,08035
-0,46%
Bitcoin
67.693,16
-0,88%
Registration Strip Icon for discussion Registrieren Sie sich, um in unseren aktiven Foren mit gleichgesinnten Anlegern zu diskutieren.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. NASDAQ
  6. Codexis Inc (CDXS)

  7. Codexis Inc (CDXS) News

CDXS

Codexis (CDXS)

Codexis Inc
Von:
Sortieren nach:
 Showing the most relevant articles for your search:NASDAQ:CDXS
DatumZeitQuelleÜberschriftSymbolFirma
22/05/202422h25GlobeNewswire Inc.Codexis to Participate in Jefferies Global Healthcare ConferenceNASDAQ:CDXSCodexis Inc
20/05/202422h05GlobeNewswire Inc.Codexis to Participate in TD Cowen 2nd Annual Sustainability WeekNASDAQ:CDXSCodexis Inc
14/05/202415h11Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:CDXSCodexis Inc
14/05/202412h52Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:CDXSCodexis Inc
14/05/202412h00GlobeNewswire Inc.Codexis Presents Groundbreaking Enzymatic Synthesis Data at TIDES USA Annual MeetingNASDAQ:CDXSCodexis Inc
02/05/202422h05GlobeNewswire Inc.Codexis Reports First Quarter 2024 Financial ResultsNASDAQ:CDXSCodexis Inc
18/04/202422h05GlobeNewswire Inc.Codexis to Report First Quarter 2024 Financial Results on May 2NASDAQ:CDXSCodexis Inc
11/04/202413h05GlobeNewswire Inc.Codexis Appoints Carole Cobb, MBA, to Strategic Advisory BoardNASDAQ:CDXSCodexis Inc
06/03/202422h02Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:CDXSCodexis Inc
28/02/202422h05GlobeNewswire Inc.Codexis Reports Fourth Quarter and Fiscal Year 2023 Financial ResultsNASDAQ:CDXSCodexis Inc
27/02/202418h15AllPennyStocks.comBiotech Rallied Strongly On Exclusive Licensing AgreementNASDAQ:CDXSCodexis Inc
26/02/202422h05GlobeNewswire Inc.Codexis Enters Exclusive Licensing Agreement for Newly Engineered Double-Stranded DNA Ligase with RocheNASDAQ:CDXSCodexis Inc
26/02/202414h05GlobeNewswire Inc.Codexis to Participate in TD Cowen 44th Annual Health Care ConferenceNASDAQ:CDXSCodexis Inc
20/02/202414h05GlobeNewswire Inc.Codexis Announces Appointment of Masad Damha, PhD, and Jim Lalonde, PhD, to Strategic Advisory BoardNASDAQ:CDXSCodexis Inc
16/02/202422h01Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:CDXSCodexis Inc
14/02/202422h51Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:CDXSCodexis Inc
14/02/202422h05GlobeNewswire Inc.Codexis to Report Fourth Quarter and Fiscal Year 2023 Financial Results on February 28NASDAQ:CDXSCodexis Inc
13/02/202422h19Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:CDXSCodexis Inc
13/02/202422h05GlobeNewswire Inc.Codexis Secures $40 Million in Strategic Financing Deal with Innovatus Capital Partners to Further Strengthen Cash Position Ahead of Key MilestonesNASDAQ:CDXSCodexis Inc
09/02/202422h06Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:CDXSCodexis Inc
01/02/202422h05GlobeNewswire Inc.seqWell and Codexis to Unveil Engineered Transposase Enzyme for Genomics Applications at AGBT General MeetingNASDAQ:CDXSCodexis Inc
24/01/202420h27Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:CDXSCodexis Inc
09/01/202414h30Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:CDXSCodexis Inc
03/01/202403h24Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CDXSCodexis Inc
03/01/202403h24Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CDXSCodexis Inc
03/01/202403h23Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CDXSCodexis Inc
03/01/202403h23Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CDXSCodexis Inc
27/12/202314h30GlobeNewswire Inc.Codexis Announces Purchase Agreement with Nestlé Health Science for CDX-7108NASDAQ:CDXSCodexis Inc
27/12/202314h30Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:CDXSCodexis Inc
13/12/202322h06GlobeNewswire Inc.Codexis and Aldevron Enter Exclusive Licensing Agreement for Codex® HiCap RNA PolymeraseNASDAQ:CDXSCodexis Inc
 Showing the most relevant articles for your search:NASDAQ:CDXS

Kürzlich von Ihnen besucht

UNSW
USTUSDT
TerraClassicUSD
BIT
UC5F0T
Unicredit Bank
BIT
UC72NE
Unicredit Bank
BOV
PETRS28
PETRS28 Ex:23,12
USOTC
AZZTF
Aztec Minerals (QB)
BIT
3LAL
Graniteshares 3x Long Al...
BIT
UC8XWK
Unicredit Bank
EU
0388T
0388T
TG
ZZA
Cinemark
NASDAQ
JEPQ
JP Morgan Nasdaq Equity ...
COIN
TSTREUR
BIT
UC86SW
Unicredit Bank
HITB
UOSUSDT
Ultra Token
BIT
BKCH
Global X Blockchain Ucit...
TSXV
MNLX
Miniluxe
BIT
F17798
Vontobel Financial Produ...
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2024 ADVFN PLC - Alle Rechte vorbehalten